Community Health Systems, Inc. CYH
2.94
0.06
2.08%
as of 25 Sep
- Market cap
- $406.1M
- P/E
- 1.6×
Follow CYH
| Older periods | Sep '25 | Dec '25 | Mar '26 | Jun '26 | |
|---|---|---|---|---|---|
P/E ratio |
+8 more quarters Free account |
1.31 | 0.82 | 0.85 | 1.79 |
P/S ratio |
0.03 | 0.03 | 0.03 | 0.04 | |
P/FCF ratio |
2.84 | 1.93 | 0.00 | 0.00 | |
P/Operating CF |
6.22 | 1.57 | (1.33) | 5.14 | |
P/B ratio |
0.00 | 0.00 | 0.00 | 0.00 | |
Price to Tangible BV |
0.00 | 0.00 | 0.00 | 0.00 | |
EV/Sales |
0.86 | 0.85 | 0.80 | 0.82 | |
EV/EBITDA |
6.19 | 5.51 | 5.12 | 5.49 | |
EV/Operating CF |
22.13 | 19.43 | 78.09 | 78.43 | |
EV/FCF |
72.26 | 48.86 | (51.25) | (54.29) | |
Quick Ratio |
1.05 | 1.06 | 1.11 | 1.14 | |
Current Ratio |
1.47 | 1.46 | 1.47 | 1.53 | |
Net Debt/EBITDA |
30.03 | 18.16 | 23.91 | 18.97 | |
Debt/Assets |
80.10% | 78.73% | 77.06% | 78.66% | |
Debt/Equity |
(8.32) | (8.97) | (8.29) | (8.23) | |
Asset Turnover |
0.93 | 0.92 | 0.91 | 0.93 | |
Operating CF/Net income |
0.53 | 2.42 | 5.12 | 1.26 | |
Capex/Depreciation |
(0.58) | (0.86) | (0.67) | (0.70) | |
Interest Coverage |
0.00 | 0.00 | 0.00 | 0.00 | |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Selling, General and Administrative Expense of Revenue |
43.93% | 43.69% | 44.59% | 43.79% | |
Intangible Assets out of Total Assets |
0.27 | 0.25 | 0.24 | 0.27 | |
Share Based Compensation of Revenue |
0.00% | 0.13% | 0.10% | 0.07% | |
Graham Net Nets |
(26.35) | (26.71) | (26.90) | (22.67) | |
Graham Number |
0.00 | 0.00 | 0.00 | 0.00 | |
Earnings Yield |
76.32% | 121.79% | 118.03% | 55.99% | |
Free Cash Flow Yield |
35.16% | 51.83% | (48.58%) | (40.22%) | |
Revenue per Share |
23.07 | 23.25 | 22.06 | 20.85 | |
Operating CF per Share |
0.52 | 1.99 | (2.21) | 0.65 | |
Capex per Share |
(0.46) | (0.70) | (0.57) | (0.56) | |
Free Cash Flow per Share |
0.05 | 1.29 | (2.77) | 0.09 | |
Cash per Share |
0.92 | 1.95 | 5.30 | 1.10 | |
Shareholders Equity per Share |
(9.52) | (8.68) | (9.11) | (8.59) | |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Book value per Share |
(9.52) | (8.68) | (9.11) | (8.59) | |
Free Cash Flow |
7.00 | 172.00 | (373.00) | 12.00 | |
Working Capital |
1,020.00 | 1,026.00 | 1,206.00 | 1,065.00 | |
Capital Expenditures |
(62.00) | (94.00) | (76.00) | (76.00) | |
Net Current Asset Value |
(11,315.00) | (11,129.00) | (10,632.00) | (10,260.00) | |
EV/EBIT |
8.29 | 7.09 | 6.63 | 7.26 | |
Capex to Sales |
0.02 | 0.03 | 0.03 | 0.03 | |
Net Profit Margin |
4.21% | 3.54% | (1.96%) | 2.48% | |
Price to Operating Income |
0.33 | 0.28 | 0.27 | 0.33 | |
| Other line items | |||||
Average Receivables |
2,101.00 | 2,181.50 | 2,232.50 | 2,202.00 | |
Average Payables |
868.00 | 877.50 | 882.00 | 841.50 | |
Average Inventory |
318.00 | 326.50 | 301.50 | 298.50 | |
Average Assets |
13,572.00 | 13,629.00 | 13,535.00 | 12,909.00 | |
Average Common Equity |
(1,433.00) | (1,417.50) | (1,459.00) | (1,288.00) |
Columns are period end dates